U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting ...

VIENNA--AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug ...

Atrial fibrillation improved when linear ablation and ethanol infusion were added to pulmonary vein isolation in a randomized ...

Introduction Atrial fibrillation (AF)-induced cardiomyopathy (AIC) is retrospectively defined after normalisation of left ...

Cardiac electrophysiology (EP) is a relatively young field. The first surgical ablation of an accessory pathway and the first ...

Learn how an occlusion-first approach improves outcomes in combined atrial fibrillation treatments, offering better ...

New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small ...

The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia.

β-blockers are effective ventricular antiarrhythmics and angiotensin-converting-enzyme (ACE) inhibitors can prevent both ventricular and atrial arrhythmia after MI. The effect of β-blockers on ...

When a cardiac arrhythmia makes itself known, it could change your life or even take it. A team of early-career researchers ...

Heart palpitations are common but they can be unnerving if you’re not sure what they mean. To find out why they happen and ...